Cite
HARVARD Citation
Yao, J. et al. (2016). Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. Lancet. 387 (10022), pp. 968-977. [Online].